These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 31452783)
1. Establishment and characterization of the gemcitabine-resistant human pancreatic cancer cell line SW1990/gemcitabine. Yu Y; Ding F; Gao M; Jia YF; Ren L Oncol Lett; 2019 Sep; 18(3):3065-3071. PubMed ID: 31452783 [TBL] [Abstract][Full Text] [Related]
2. [Establish a gemcitabine-resistant pancreatic cancer cell line SW1990/GZ and research the relationship between SW1990/GZ and pancreatic cancer stem cell]. An Y; Yao J; Wei JS; Lu ZP; Cai HH; Dai CC; Qian ZY; Xu ZK; Miao Y Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):999-1003. PubMed ID: 21054984 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-429 sensitizes pancreatic cancer cells to gemcitabine through regulation of PDCD4. Yu G; Jia B; Cheng Y; Zhou L; Qian B; Liu Z; Wang Y Am J Transl Res; 2017; 9(11):5048-5055. PubMed ID: 29218103 [TBL] [Abstract][Full Text] [Related]
4. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB. Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555 [TBL] [Abstract][Full Text] [Related]
5. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA. Gu WJ; Liu HL Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071 [TBL] [Abstract][Full Text] [Related]
6. [Drug resistance and activity changes of thioredoxin reductase in pancreatic cancer cells strain SW1990 induced by gemcitabine]. Niu BZ; Chen G; Li LJ; Wu YD; Zhao YP Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):606-10. PubMed ID: 16274042 [TBL] [Abstract][Full Text] [Related]
7. [A pilot study on the impact of the drug resistance on the radioresistance in human pancreatic cancer cell lines]. Chen G; Zhao YP; Jiang H; Guo JC; Zhang LY; Niu BZ; Wu WW Zhonghua Wai Ke Za Zhi; 2006 Jul; 44(13):921-3. PubMed ID: 17067488 [TBL] [Abstract][Full Text] [Related]
8. Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition. Wei W; Wang J; Hu Y; Chen S; Liu J Exp Ther Med; 2023 Jan; 25(1):7. PubMed ID: 36545274 [TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of circular RNA expression profiles associated with gemcitabine resistance in pancreatic cancer cells. Xu C; Yu Y; Ding F Oncol Rep; 2018 Jul; 40(1):395-404. PubMed ID: 29781033 [TBL] [Abstract][Full Text] [Related]
10. Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer. Chen M; Xue X; Wang F; An Y; Tang D; Xu Y; Wang H; Yuan Z; Gao W; Wei J; Zhang J; Miao Y Oncol Rep; 2012 Jan; 27(1):265-9. PubMed ID: 21956451 [TBL] [Abstract][Full Text] [Related]
11. MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial-Mesenchymal Transition. Wei W; Wang L; Xu L; Liang J; Teng L ACS Omega; 2021 Nov; 6(47):31435-31446. PubMed ID: 34869970 [TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling. Zhou M; Ye Z; Gu Y; Tian B; Wu B; Li J Int J Clin Exp Pathol; 2015; 8(1):38-52. PubMed ID: 25755691 [TBL] [Abstract][Full Text] [Related]
13. [Establishment, characterization, and biological analysis of pancreatic adenocarcinoma cell strain SW1990/FU]. Guo JC; Zhao YP; Liao Q; Chen G; Zhang LY Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):592-6. PubMed ID: 16274039 [TBL] [Abstract][Full Text] [Related]
14. [Down regulation of mitogen activated protein kinase phosphatase-1 mediate acquired multidrug resistance in pancreatic adenocarcinoma cell line SW1990/Fu]. Guo JC; Zhao YP; Liao Q; Chen G; Zhu Y Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):473-5. PubMed ID: 16772084 [TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of GCS gene in human pancreatic cancer cell SW1990 and its drug-resistant sublines]. Bu GB; Zhao YP; Chen G; Zhang TP; Li LJ; Wu YD Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1342-4. PubMed ID: 17217822 [TBL] [Abstract][Full Text] [Related]
16. Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling. Wang B; Shen C; Li Y; Zhang T; Huang H; Ren J; Hu Z; Xu J; Xu B Onco Targets Ther; 2019; 12():5751-5765. PubMed ID: 31410021 [No Abstract] [Full Text] [Related]
17. Nardoguaianone L Isolated from Zheng YD; Ma LM; Lu JJ; Chai T; Naghavi MR; Ma JY; Sang CY; Yang JL Molecules; 2022 Oct; 27(20):. PubMed ID: 36296442 [TBL] [Abstract][Full Text] [Related]
18. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379 [TBL] [Abstract][Full Text] [Related]
19. Hyperthermia enhances the sensitivity of pancreatic cancer SW1990 cells to gemcitabine through ROS/JNK signaling. Jin H; Zhao Y; Yang J; Zhang X; Ma S Oncol Lett; 2018 Nov; 16(5):6742-6748. PubMed ID: 30405817 [TBL] [Abstract][Full Text] [Related]
20. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer. Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]